InMode (INMD, Health Care Equipment) Stock Valuation & Fair Value Quality business with a solid forward outlook
InMode (INMD, Health Care Equipment) trades at a blended P/E of 10.4, about 36% below its historical normal valuation, with a forward growth estimate of 3.8% and a PEG of 2.70. Analysts' one-year estimates have been hit 17% of the time. Priced at its historical normal P/E of 16.1 on the same blended earnings, the 2026-09-18 close of $14.35 corresponds to about $22.30 a share. This is a valuation reference, not a price target.
- Price $14.19 at the 2026-09-23 close, 4.0% below the 20-day average ($14.78) and 5.6% below the 50-day ($15.03).
- RSI (14) at 29.9.
- 52-week range $12.76 to $16.62: the price is 14.6% below the high and 11.2% above the low.
The Street vs SeerForecast
Wall Street's mean price target for INMD is $16.17 across 3 analysts, 13.9% above the current price. Our SeerForecast read of the same stock, formed without analyst targets: quality business with a solid forward outlook. When the two disagree, start your digging there.
Valuation flags
- Low growth forecast
Verdict history
tickerseer's rating moved from fairly valued (2026-07-31) to quality business with a solid forward outlook (2026-09-21).
Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.
Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.
Frequently asked questions
Is InMode stock overvalued?
At a blended P/E of 10.4 versus its historical normal P/E of 16.1, InMode trades about 36% below its typical valuation, with a PEG of 2.70 on 3.8% forward growth. tickerseer currently rates it quality business with a solid forward outlook.
What is InMode's fair value and PEG?
InMode trades at a blended P/E of 10.4 against a historical normal P/E of 16.1, a PEG of 2.70, and a forward growth estimate of 3.8%. Priced at its historical normal P/E of 16.1 on the same blended earnings, the 2026-09-18 close of $14.35 corresponds to about $22.30 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of InMode changed?
tickerseer's rating moved from fairly valued (2026-07-31) to quality business with a solid forward outlook (2026-09-21).
What is the analyst price target for InMode?
The mean Wall Street price target for InMode is $16.17 across 3 analysts, 13.9% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Health Care Equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.